Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azelastine hydrochloride and fluticasone propionate nasal spray to improve PAP adherence in obstructive sleep apnea
TCTR20220308003Phase 4Completed
- Sponsor
- Thammasat University Hospital
- Start
- Mar 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azelastine, fluticasone propionate in obstructive sleep apnea hypopnea syndrome (OSAHS), sponsored by Thammasat University Hospital. Started Mar 2022; status: completed.
02
Drugs
azelastinefluticasone propionate
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on TCTR20220308003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220308003.